Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement

被引：23

作者：

Einhorn, Lawrence H. ^{[1
]}

Grunberg, Steven M. ^{[2
]}

Rapoport, Bernardo ^{[3
]}

Rittenberg, Cynthia ^{[4
]}

Feyer, Petra ^{[5
]}

机构：

[1] Indiana Univ, Mel & Bren Simon Canc Ctr, Div Hematol Oncol, Indianapolis, IN 46202 USA

[2] Univ Vermont, Med Ctr, Burlington, VT 05401 USA

[3] Med Oncol Ctr Rosebank, ZA-2193 Johannesburg, South Africa

[4] Rittenberg Oncol Consultants, Metairie, LA 70005 USA

[5] Viventes Clin Beniu Needcoellin, Clin Radiotherapy, Berlin, Germany

来源：

SUPPORTIVE CARE IN CANCER | 2011年 / 19卷

关键词：

Antiemetics; Multiday chemotherapy; Rescue antiemetics; INDUCED NAUSEA; ONDANSETRON; DEXAMETHASONE; EMESIS; PROPHYLAXIS; APREPITANT; PREVENTION;

D O I：

10.1007/s00520-010-0920-z

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

This paper will evaluate various topics related to chemotherapy-induced nausea and vomiting. The results published reflect a consensus conference convened in Perugia, Italy. The topics discussed include antiemetic therapy of multiple-day chemotherapy, high-dose chemotherapy, and rescue antiemetics.

引用

收藏

页码：S1 / S4

页数：4

相关论文

共 25 条

[1]

Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support [J].

Ballen, KK ;

Hesketh, AM ;

Heyes, C ;

Becker, PS ;

Emmons, RVB ;

Fogarty, K ;

LaPointe, J ;

Liu, Q ;

Hsieh, CC ;

Hesketh, PJ .

BONE MARROW TRANSPLANTATION, 2001, 28 (11) :1061-1066

[2]

BALTZER L, 1993, P AN M AM SOC CLIN, V12, P462

[3]

Brames MJ, 2009, CARE CANC S, V17, P871

[4]

Electroacupuncture for refractory acute emesis caused by chemotherapy [J].

Choo, Su-Pin ;

Kong, Keng-He ;

Lim, Wan-Teck ;

Gao, Fei ;

Chua, Karen ;

Leong, Swan-Swan .

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2006, 12 (10) :963-969

[5]

The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours [J].

Cook, AM ;

Dzik-Jurasz, ASK ;

Padhani, AR ;

Norman, A ;

Huddart, RA .

BRITISH JOURNAL OF CANCER, 2001, 85 (11) :1624-1626

[6]

Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer [J].

Einhorn, Lawrence H. ;

Brames, Mary J. ;

Dreicer, Robert ;

Nichols, Craig R. ;

Cullen, Michael T., Jr. ;

Bubalo, Joseph .

SUPPORTIVE CARE IN CANCER, 2007, 15 (11) :1293-1300

[7]

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement [J].

Einhorn, LH ;

Rapoport, B ;

Koeller, J ;

Grunberg, SM ;

Feyer, P ;

Rittenberg, C ;

Aapro, M .

SUPPORTIVE CARE IN CANCER, 2005, 13 (02) :112-116

[8]

ONDANSETRON - A NEW ANTIEMETIC FOR PATIENTS RECEIVING CISPLATIN CHEMOTHERAPY [J].

EINHORN, LH ;

NAGY, C ;

WERNER, K ;

FINN, AL .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (04) :731-735

[9]

Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study [J].

Fabi, Alessandra ;

Ciccarese, Mariangela ;

Metro, Giulio ;

Savarese, Antonella ;

Giannarelli, Diana ;

Nuzzo, Carmen M. ;

Russillo, Michelangelo ;

Sperduti, Isabella ;

Carbone, Ilaria ;

Bria, Emilio ;

Cognetti, Francesco .

SUPPORTIVE CARE IN CANCER, 2008, 16 (12) :1375-1380

[10]

ONDANSETRON VERSUS ONDANSETRON, DEXAMETHASONE, AND CHLORPROMAZINE IN THE PREVENTION OF NAUSEA AND VOMITING ASSOCIATED WITH MULTIPLE-DAY CISPLATIN CHEMOTHERAPY [J].

FOX, SM ;

EINHORN, LH ;

COX, E ;

POWELL, N ;

ABDY, A .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (12) :2391-2395